Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Movement Disorders Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Movement Disorders
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Quantitative motor assessment in X-linked dystonia parkinsonism
Federico Parisi, PhD
07:00 AM - 05:00 PM EDT Abstract 002 - DYSTONIA IN PATIENTS WITH VARIANTS IN ADAR
Felixe Pelletier, MD
07:00 AM - 05:00 PM EDT Abstract 003 - A case of TUBB4A-related hypomyelinating leukodystrophy with abnormal movements responsive to levodopa/carbidopa
Adrienne Visani
07:00 AM - 05:00 PM EDT Abstract 004 - COVID-19 Associated Diffuse Myoclonus and Dystonia (CADMAD) Syndrome: An Immune Mediated Para-Infectious or Post-Infectious Condition?
Saleem M. Al Mawed, MD
07:00 AM - 05:00 PM EDT Abstract 005 - Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies
Lorraine Cuffe
07:00 AM - 05:00 PM EDT Abstract 006 - Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets
Marie-Eve Gendron
07:00 AM - 05:00 PM EDT Abstract 008 - Rescue Strategies in Dystonia Before Deep Brain Stimulation (DBS): The Value Of Switching Botulinum Toxin
Carolina Gorodetsky, MD
07:00 AM - 05:00 PM EDT Abstract 010 - Remote assessment of action tremors during COVID-19: A pooled meta-analysis of transcutaneous afferent patterned stimulation in Parkinson’s Disease and Essential Tremor
Ruta Deshpande
07:00 AM - 05:00 PM EDT Abstract 011 - Essential tremor patients managed through in-person and telemedicine have similar experiences with prescribed non-invasive neuromodulation therapy
Salima Brillman, MD
07:00 AM - 05:00 PM EDT Abstract 012 - Curative Stroke: Radiographic Evidence for Proposed Essential Tremor Circuitry
Saad I. Yazdani, MD
07:00 AM - 05:00 PM EDT Abstract 013 - A Comparative Study of Cognition and Quality of Life of Essential Tremor and Tremor Dominant Parkinson's Disease
Butchi Raju Garuda, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 014 - Racial Difference of [123I] Ioflupane Uptakes in Patients with Tremor and Parkinsonian Syndrome: A Retrospective Chart Review Study
Juebin Huang, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 015 - Long Term Effects of VIM DBS on Cerebellar Outflow Tremor in Abetalipoproteinemia
Jennifer Hislop, MD
07:00 AM - 05:00 PM EDT Abstract 016 - Electrophysiology Screening for Functional Tremor Amongst Essential Tremor Patients Referred for Surgical Treatment
Claudia Z. Chou, MD
07:00 AM - 05:00 PM EDT Abstract 017 - Association of Handedness with Cognitive Outcomes in Essential Tremor Patients with Bilateral Deep Brain Stimulation: A Single-Center Retrospective Longitudinal Analysis
Joseph E. Malone, MD
07:00 AM - 05:00 PM EDT Abstract 018 - Age of Onset and Deep Brain Stimulation in a Cohort of Essential Tremor
Fariha Jamal
07:00 AM - 05:00 PM EDT Abstract 019 - Long Term Safety and Efficacy of Gamma Knife Thalamotomy for Essential Tremor: A Single Center Study
Marisa McGhee, MD
07:00 AM - 05:00 PM EDT Abstract 020 - Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) associated with SARS-CoV-2 infection: post-infectious neurological complication with benign prognosis
Enrique Urrea-Mendoza, MD
07:00 AM - 05:00 PM EDT Abstract 021 - Gene therapy in a rat model of Christianson syndrome, an epileptic encephalopathy with ataxia
Collin J. Anderson, PhD
07:00 AM - 05:00 PM EDT Abstract 022 - Cerebellar Impulsivity-Compulsivity Assessment (CIA): A Scale to Measure Impulsive and Compulsive Behaviors in Cerebellar Disorders
Chi-Ying (Roy) Lin, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 023 - Improving Episodic Ataxia Diagnosis by Combination of WGS and RNA-seq in Complex Cases
Sebastien Audet
07:00 AM - 05:00 PM EDT Abstract 024 - Analysis of Diffusion Tensor Parameters in Spinocerebellar Ataxia Type 3 and Type 10 Patients
07:00 AM - 05:00 PM EDT Abstract 025 - The Many Faces of Spinocerebellar Ataxia type 8: A Video Series and Review of the Literature
Deepal P. Shah-Zamora, MD
07:00 AM - 05:00 PM EDT Abstract 026 - Sleep And Autonomic Dysfunction In Idiopathic Sporodic Cerebellar Ataxia
Meena Lanjiwar, DM
07:00 AM - 05:00 PM EDT Abstract 027 - Functionality and disease severity in Spinocerebellar Ataxias
07:00 AM - 05:00 PM EDT Abstract 028 - Health-related quality of life in patients with inherited ataxia in Ireland
Poornima Jayadev Menon, MbBchBAO, MRCPI
07:00 AM - 05:00 PM EDT Abstract 029 - Quality of Life in Fragile X-associated Tremor Ataxia Syndrome
Deborah H. Hall, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 030 - Using Item 8 of the Abnormal Involuntary Movement Scale (AIMS) to Assess Improvement in Patients with Tardive Dyskinesia
Leslie Citrome
07:00 AM - 05:00 PM EDT Abstract 031 - Alternative Medications for Paroxysmal Kinesigenic Dyskinesia
Travis Larsh, MD
07:00 AM - 05:00 PM EDT Abstract 032 - Post-infectious Akathisia in Epstein-Barr Virus Encephalitis with Bilateral Basal Ganglia Involvement and Clinical Improvement with Trihexyphenidyl
Navpreet K. Bains, DO
07:00 AM - 05:00 PM EDT Abstract 033 - Management practices and long-term follow up of pediatric functional (psychogenic) movement disorder at a tertiary care center
Mariam Hull, MD
07:00 AM - 05:00 PM EDT Abstract 034 - EEG correlates of frontal cortex mediated inhibitory control in Tourette syndrome
Alonso Zea Vera, MD
07:00 AM - 05:00 PM EDT Abstract 035 - Rhabdomyolysis Secondary to Severe Tic Fits
Ka Loong K. Au, MD
07:00 AM - 05:00 PM EDT Abstract 036 - Multi-Level and Multi-Pattern Lower- And Upper-Limb Spasticity Treatment With IncobotulinumtoxinA In Children And Adolescents With Cerebral Palsy
Edward R. Dabrowski, MD
07:00 AM - 05:00 PM EDT Abstract 037 - Consistent Dose Over Time and Within Treatment Interval Groups With OnabotulinumtoxinA: Analysis From the Adult Spasticity International Registry (ASPIRE)
Alberto Esquenazi, MD
07:00 AM - 05:00 PM EDT Abstract 038 - Phenotyping Spasticity-associated Tonic Spasms: Implications for Therapy
Hesham A. Abboud, MD
07:00 AM - 05:00 PM EDT Abstract 039 - Drug-induced Myoclonus in a Patient on Continuous Dobutamine Infusion
Mario P. Zamora
07:00 AM - 05:00 PM EDT Abstract 040 - Plasma Neurofilament Light (NfL) Levels Do Not Correlate with Severity of Clinical Symptoms in Manifest Huntington’s Disease (HD)
Jody Corey-Bloom, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 041 - How Well Does the Composite Unified Huntington’s Disease Rating Scale (cUHDRS) Reflect Disease Progression in Huntington’s disease (HD)?
Jody Corey-Bloom, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 042 - Spatial-Epidemiological Analysis of Proximity to Specialty Center Care for Medicare Beneficiaries with Huntington Disease – Implications for Programmatic Solutions to Address Unmet Needs in Huntington Disease Populations
Thanh Phuong Pham Nguyen, PharmD, MBA, MSCE
07:00 AM - 05:00 PM EDT Abstract 043 - Burden of Illness Among US Medicare Beneficiaries with Late-Onset Huntington’s Disease
Jamie Ta
07:00 AM - 05:00 PM EDT Abstract 044 - Defining Utility Values for Chorea Health States in Patients With Huntington’s Disease
07:00 AM - 05:00 PM EDT Abstract 045 - Detecting Disease Onset in Huntington’s Disease with a Simple Balance Assessment
Jody Corey-Bloom, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 046 - Clinical Characteristics of Late-Onset Huntington’s Disease in North Americans from the Enroll-HD Study
07:00 AM - 05:00 PM EDT Abstract 047 - Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease
Sam Leo, PharmD
07:00 AM - 05:00 PM EDT Abstract 048 - Atypical gait in a patient with Huntington’s disease (HD): Functional movement disorders in the spectrum of motor phenotypes in HD
Humberto Leal Bailey, MD
07:00 AM - 05:00 PM EDT Abstract 049 - Understanding Deficits in the Genetics, Recognition, and Management of Huntington Disease Among Neurologists: Results from a CME-Certified Survey
Thomas Finnegan, Jr., PhD
07:00 AM - 05:00 PM EDT Abstract 050 - Prodromal Parkinson's disease - insights from UK Biobank
Duncan Street, MBBS, MRCP
07:00 AM - 05:00 PM EDT Abstract 051 - The heartbeat evoked potential as a novel marker of autonomic function in Parkinson disease.
Paul Beach, DO, PhD
07:00 AM - 05:00 PM EDT Abstract 052 - Orthostatic Hypotension in Early Parkinson’s Disease: A Retrospective Chart Review
Melanie Braun, MD
07:00 AM - 05:00 PM EDT Abstract 053 - Effect of the Initial Maintenance Dose of Droxidopa on Treatment Persistence in Patients With Neurogenic Orthostatic Hypotension
Steven Kymes
07:00 AM - 05:00 PM EDT Abstract 054 - Determinants of quality of life in a large, online cohort of individuals with Parkinson’s disease
Meredith Bock, MD
07:00 AM - 05:00 PM EDT Abstract 055 - Quality of Life in African American and White Parkinson’s Disease Patients
Deborah H. Hall, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 056 - Pure apathy and cognition in early stage drug-naïve patients with Parkinson’s disease
Amputch Karukote, MD
07:00 AM - 05:00 PM EDT Abstract 057 - Understanding Sex-Specific Neuroanatomical Correlation Between Neuropsychological Scores And Higher-Order Diffusion MRI Measures in Parkinson’s Disease
Virendra R. Mishra, PhD
07:00 AM - 05:00 PM EDT Abstract 058 - Glycated Hemoglobin Levels are Inversely Correlated with FDG-PET Uptake in Non-diabetic Patients with Parkinson's Disease
Elliot J. Hogg, MD
07:00 AM - 05:00 PM EDT Abstract 059 - Feasibility and Outcomes of Caregiver Peer Mentoring in Advanced Parkinson’s Disease
Jori Fleisher, MD, MSCE, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 060 - Relationship Between Dysphagia And Nutritional State In Patients With Parkinson´s Disease.
Hector Tellez
07:00 AM - 05:00 PM EDT Abstract 061 - A Retrospective Study of Pimavanserin in Patients with Parkinson’s Disease: a Single-center Experience.
Luhua Wei
07:00 AM - 05:00 PM EDT Abstract 062 - The Millon Behavioral Medicine Diagnostic (MBMD): A psychological characterization of individuals with Parkinson’s disease (PD) prior to deep brain stimulation (DBS)
Shannon O'Neill, PhD
07:00 AM - 05:00 PM EDT Abstract 063 - “Needle Phobia” in Patients with Parkinson’s Disease (PD) Experiencing OFF Episodes is Uncommon
Aldina Imamovic
07:00 AM - 05:00 PM EDT Abstract 064 - Correlation between malnutrition and clinical characteristics in a Mexican population with Parkinson's Disease
José David García Romero
07:00 AM - 05:00 PM EDT Abstract 065 - Peripheral Immunity in Parkinson’s Disease
Lisanne Dommershuijsen
07:00 AM - 05:00 PM EDT Abstract 066 - Microbial Translocation in Patients with Parkinson's Disease at the University Teaching Hospital, Lusaka, Zambia: A Case Control Study
Lorraine Chishimba, MBChB, MMED
07:00 AM - 05:00 PM EDT Abstract 067 - Effect of REM sleep behavior disorder on neuropsychiatric disturbances in early drug-naïve Parkinson's disease
Amputch Karukote, MD
07:00 AM - 05:00 PM EDT Abstract 068 - A Novel Device for Continuous Assessment of Wrist Rigidity in Parkinson’s Disease
Zeyang Yu, PhD
07:00 AM - 05:00 PM EDT Abstract 069 - Utilization of a novel frog-in-maze finger tapping task to differentiate Parkinson’s disease freezers from non-freezers
Aaron S. Kemp, PhD
07:00 AM - 05:00 PM EDT Abstract 070 - MDS-UPDRS ratings for Parkinson’s Disease in the COVID-19 setting
Christopher Goetz, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 071 - Inter-rater agreement of the modified motor United Parkinson’s Disease Rating Scale (mUPDRS-III) for tele-health evaluation in Mexican Parkinson’s disease (PD) patients during the COVID19 era.
R Arturo Abundes-Corona, MD
07:00 AM - 05:00 PM EDT Abstract 072 - Correlation between BMI and Total Daily Levodopa Requirements with Levodopa-Carbidopa Intestinal Gel Therapy: Results from Phase 3 Clinical Trials
Leonard Verhagen Metman, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 073 - Istradefylline Effects on Tremor Dominant (TD) and Postural Instability and Gait Difficulty (PIGD) Motor Subtypes
Fernando L. Pagan, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 074 - Wearable Fitness Trackers for People with Parkinson's Disease: A Resource Informed by Experience
Sarah Ingersoll, RN, PHN
07:00 AM - 05:00 PM EDT Abstract 075 - A Novel Tele-rehabilitation Program Aimed at Reducing Fall Risk in Parkinson’s Disease Patients
Mitra Afshari, MD
07:00 AM - 05:00 PM EDT Abstract 076 - Contribution of Motor Symptoms and Cognition on Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) Performance in Parkinson’s Disease.
Travis H. Turner, PhD
07:00 AM - 05:00 PM EDT Abstract 077 - Medical Â鶹´«Ã½Ó³»­ Improves Knowledge Among Neurologists of Newly Approved Pharmacotherapies for the Management of Wearing-Off in Parkinson Disease
Jovana Lubarda
07:00 AM - 05:00 PM EDT Abstract 078 - P 300 Latency in Patients With Parkinson’s Disease Without Dementia and its Association with Motor Symptoms and Cognitive Performance
Shrivarthan R
07:00 AM - 05:00 PM EDT Abstract 079 - Inhaled Levodopa (LD) as a Treatment for Parkinson’s Disease (PD) Patients in an Emergency Setting
Yasar A. Torres-Yaghi, MD
07:00 AM - 05:00 PM EDT Abstract 080 - Developing a drug-device combination for patients with Parkinson’s disease during the COVID19 pandemic
Ryan J. Case, PhD
07:00 AM - 05:00 PM EDT Abstract 081 - Adopting a multidisciplinary telemedicine approach for falls prevention in Parkinson´s disease
Esther Cubo Delgado, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 082 - Levodopa Unresponsive Freezing of Gait: Defining the Gait and Non-motor Phenotype
Tuhin Virmani, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 083 - A demonstration of validity of Digital analysis of human finger, hand and foot movement with video taping
June Yin, MD
07:00 AM - 05:00 PM EDT Abstract 084 - Is the MyCap Finger Tapping Smartphone Application Effective in Differentiating Healthy Controls from Parkinson’s disease Patients? Preliminary Pilot Study Data
Susmit Tripathi, MD
07:00 AM - 05:00 PM EDT Abstract 085 - Health Â鶹´«Ã½Ó³»­ Needs of Patients with Parkinson’s Disease
Katherine Barnes, MD
07:00 AM - 05:00 PM EDT Abstract 086 - Cross-Sectional Profile of Most Bothersome Problems as Reported Directly by Individuals with Parkinson’s Disease
Feiby L. Nassan
07:00 AM - 05:00 PM EDT Abstract 087 - Survival Based on Genetic and Clinical Features in Parkinson’s Disease
Sushma Kola, MD
07:00 AM - 05:00 PM EDT Abstract 088 - Baseline characteristics of LRRK2 G2019S carriers in the Virtual Assessment of LRRK2 carriers to Optimize Research in Parkinson’s Disease (VALOR-PD) study
Ruth Schneider, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 089 - Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk
Yingnan Han
07:00 AM - 05:00 PM EDT Abstract 090 - a-Synuclein in Sympathetic Nerve Fibers Distinguishes among Genetic Forms of Parkinson’s Disease
Risa Isonaka
07:00 AM - 05:00 PM EDT Abstract 091 - Longitudinal Cortical Thickness Changes in GBA-Positive Parkinson’s Disease
Michela Leocadi, MSc
07:00 AM - 05:00 PM EDT Abstract 092 - GCH1 Mutations in Hereditary Spastic Paraplegia
Parizad Varghaei, MD
07:00 AM - 05:00 PM EDT Abstract 093 - Effects of Chelation Therapies in Hypermanganesemia Secondary to a SLC39A14 Mutation
John McCarron
07:00 AM - 05:00 PM EDT Abstract 094 - DBS for Medically-Refractory Myoclonus Dystonia Syndrome Caused by Maternal Uniparental Disomy of Chromosome 7 Associated with Russell-Silver Syndrome
Henry P. Moore, MD
07:00 AM - 05:00 PM EDT Abstract 095 - Novel Dentato-Olivo-Luysian Atrophy in a Greek Family
Sohaila A. Alshimemeri, MD
07:00 AM - 05:00 PM EDT Abstract 096 - Role of Apolipoprotein E genotype in the occurrence of atypical parkinsonian syndromes
Amina Nasri, MD
07:00 AM - 05:00 PM EDT Abstract 097 - Clinical Outcomes from Deep Brain Stimulation with Multiple Independent Current Control (MICC) in Parkinson's Disease
Alina Shub, PA
07:00 AM - 05:00 PM EDT Abstract 098 - Sex Disparities in the Utilization of Deep Brain Stimulation for Essential Tremor and Parkinson Disease
Lisa M. Deuel, MD
07:00 AM - 05:00 PM EDT Abstract 099 - Patient reported baseline measures in RAD-PD reveal marked heterogeneity in a DBS cohort
Joohi Jimenez Shahed, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 100 - Real-World Outcomes Using a Novel Directional Lead from a Multicenter DBS Registry for Parkinson's Disease
Guenther Deuschl, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 101 - DBS Directional programming – Institution based study of programming in PD and ET patients
Maria Camila Moreno Escobar, MD
07:00 AM - 05:00 PM EDT Abstract 102 - A retrospective analysis of contact location and directional stimulation in subthalamic deep brain stimulation for Parkinson’s disease
Caroline Johnson
07:00 AM - 05:00 PM EDT Abstract 103 - Rechargeable Implantable Neurostimulators: How Much Battery Capacity Remains After 10 Years?
07:00 AM - 05:00 PM EDT Abstract 104 - Safety of Simple versus Advanced Patient Programmer: Results from Product Surveillance Registry
Mya C. Schiess, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 105 - Pallidal Deep Brain Stimulation Induced Keyboard Typing Dysfunction
Joshua Wong, MD
07:00 AM - 05:00 PM EDT Abstract 106 - Utilization of New Visualization Software for Deep Brain Stimulation Programming Using a Multiple-Source, Constant-Rechargeable System
Jason L. Aldred, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 107 - An Integrated Remote Care platform for Deep Brain Stimulation Patient Programming: Safety and Feasibility study
Peter A. Silburn, MBBS, PhD, FRACP
07:00 AM - 05:00 PM EDT Abstract 108 - Real-World Assessment of DBS Outcomes Using a 16-Contact Device Capable of Multiple Independent Current Control: A Retrospective Outcomes Study
Corneliu C. Luca, MD
07:00 AM - 05:00 PM EDT Abstract 110 - Incidence and Prevalence of Motor Fluctuations and Deep Brain Stimulation in Parkinson’s disease: A Comparison Between Two Population-based Cohorts in South East Minnesota
Cole D. Stang
07:00 AM - 05:00 PM EDT Abstract 111 - Sex Differences in Deep Brain Stimulation Implants, Management and Levodopa Adjustments in Two Population-based Parkinsonism Cohorts in Minnesota
Emanuele Camerucci, MD
07:00 AM - 05:00 PM EDT Abstract 112 - Increases in subthalamic neuronal firing rate and ß frequency neuronal activity in the two hemispheres associated with severity of Parkinson’s disease
Ping Zhuang, PhD
07:00 AM - 05:00 PM EDT Abstract 113 - Identifying Neurophysiologic Biomarkers that Differentiate the Dorsal and Ventral Subthalamic Nucleus in Parkinson's Patients
Jeffrey Nie
07:00 AM - 05:00 PM EDT Abstract 114 - Â鶹´«Ã½Ó³»­al Intervention Improves deep brain stimulation (DBS) Knowledge
Nasrin E. Moin, DNP, CNS, NP-C
07:00 AM - 05:00 PM EDT Abstract 115 - Emerging Evidence for Deep Brain Stimulation in Refractory Post-Hypoxic Myoclonus
Aminah Abdul Razzack
07:00 AM - 05:00 PM EDT Abstract 116 - Real-World Outcomes of the use of Deep Brain Stimulation for the Treatment of Cervical Dystonia: A Single-Center Experience.
Alfonso Enrique Martinez Nunez, MD
07:00 AM - 05:00 PM EDT Abstract 117 - Identifying care gaps in Parkinson’s Disease patients eligible for Device-Aided Therapies: Results from using the MANAGE-PD tool in patients from G7 countries
Hubert H. Fernandez, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 118 - Sustained Improvements in Motor and Non-Motor Symptoms in Advanced Parkinson’s Disease Patients Treated with Carbidopa Levodopa Enteral Suspension in a ‘Real-World’ Study: Interim Results of the Multinational DUOGLOBE Study With at Least 24 Months Follow-Up
Jason L. Aldred, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 119 - Clinically Meaningful Improvement in Quality of Life Sustained at 24 months After Initiation of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients in USA: Interim Results from the PROviDE Study
Rajesh Pahwa, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 120 - A Retrospective Study Evaluating the Use of Anti-Parkinsonian Medications in Patients with Advanced Parkinson’s Disease Who Are Treated with Levodopa-Carbidopa Intestinal Gel and Deep Brain Stimulation: The PD-DUAL Study
Jason L. Aldred, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 121 - Clinical Characteristics of Patients who Develop Gait Instability after Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy
Lauren Jackson, MD
07:00 AM - 05:00 PM EDT Abstract 122 - Practice Landscape of Lesional Procedures for Movement Disorders in North America
Mustafa S. Siddiqui, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 125 - Survey-based Study of Marijuana Use in Parkinson's Disease Patients
Jacob Paulson
07:00 AM - 05:00 PM EDT Abstract 126 - Long-term Safety and Clinical Effects of Nilotinib in Parkinson’s Disease
Fernando L. Pagan, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 127 - Long-term Efficacy of Opicapone in the Reduction of ON-time with Troublesome Dyskinesia in Parkinson’s Disease Patients with Motor Fluctuations and Reporting Troublesome Dyskinesia
Olga Klepitskaya, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 128 - ADS-5102 Significantly Increases ON Time Without Dyskinesia: Pooled Patient Diary Analyses from Parkinson’s Disease Pivotal Trials
Robert A. Hauser, MD, MBA, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 129 - Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects
07:00 AM - 05:00 PM EDT Abstract 130 - Pharmacokinetic analysis of levodopa and carbidopa following subcutaneous infusion: A population pharmacokinetics model
Tal Birnberg
07:00 AM - 05:00 PM EDT Abstract 131 - Real-world characteristics and treatment persistence in patients initiating CLES: Results from a cohort of 1290 patients in USA
Fernando L. Pagan, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 132 - A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia
Joseph Jankovic, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 133 - Efficacy and Safety of IncobotulinumtoxinA for Upper- or Combined Upper- and Lower-Limb Spasticity in Children and Adolescents with Cerebral Palsy: Results of the Phase 3 XARA Study
Edward R. Dabrowski, MD
07:00 AM - 05:00 PM EDT Abstract 134 - Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity: 2nd Interim Results From a Phase IV, Prospective, Observational, Multicenter Study
07:00 AM - 05:00 PM EDT Abstract 135 - Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson’s Disease and “OFF” Episodes
Jennifer S. Hui, MD
07:00 AM - 05:00 PM EDT Abstract 136 - Incidence of Adverse Events Associated With Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated With Huntington’s Disease
Karen E. Anderson
07:00 AM - 05:00 PM EDT Abstract 137 - Results from a Phase 1b Study of UCB0599, an Orally Available, Brain-penetrant Inhibitor of Alpha-synuclein (ASYN) Misfolding in People Living with Parkinson’s Disease (PD)
Johan W. Smit, PhD
07:00 AM - 05:00 PM EDT Abstract 138 - Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinson’s Disease- A Pilot study.
Kanchana S. Pillai, MD
07:00 AM - 05:00 PM EDT Abstract 139 - Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral Carbidopa/Levodopa in Advanced Parkinson’s Disease Patients: Design of a Phase 3, Randomized, Double-Blind, Double-Dummy, Active Controlled 12-Week Trial
Maurizio Facheris, MD, MSc
07:00 AM - 05:00 PM EDT Abstract 140 - Feasibility and tolerability randomized clinical trial of golf versus Tai Chi for people with moderate Parkinson’s Disease
Remy Johnson
07:00 AM - 05:00 PM EDT Abstract 141 - CVT-301 (Levodopa Inhalation Powder): Meta-Analysis of Safety in Patients With Parkinson’s Disease (PD)
Peter A. LeWitt, MD
07:00 AM - 05:00 PM EDT Abstract 142 - Improvement in Unified Parkinson's Disease Rating Scale Motor Scores (UPDRS-III) After CVT-301 Treatment is Associated With Improved Scores in the Parkinson's Disease Questionnaire Activities of Daily Living (PDQ-39ADL)
Iresha Abeynayake
07:00 AM - 05:00 PM EDT Abstract 143 - Uptake of Telehealth in Parkinson’s Disease Clinical Care and Research During COVID-19 Pandemic: a Parkinson Study Group Survey
Vikram Shivkumar, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 144 - Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson Disease: Interim Report on Tolerability
Maureen Leehey, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 145 - Chorea Characteristics and Medication Use in Patients with Huntington Disease: Current Data from Enroll-HD
Erin Furr-Stimming, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 146 - Evolving inclusion criteria in early manifest Huntington’s disease (HD) to address striatal atrophy: Lessons from HD-GeneTRX-1, the first gene therapy trial
Erin Furr-Stimming, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 147 - Clustering and Prediction of Disease Progression Trajectories in Huntington’s Disease: an Analysis of the Enroll-HD and REGISTRY Database Using a Machine Learning Approach
Jinnie Ko
07:00 AM - 05:00 PM EDT Abstract 148 - Evaluating the Impact of Levodopa-Induced Dyskinesia and OFF Time in Persons Affected by Parkinson’s Disease: Results of a PMD Alliance Survey
Jill M. Farmer, DO, MPH
07:00 AM - 05:00 PM EDT Abstract 149 - Survey of the Effects of the COVID19 Era on Parkinson’s Disease Patients
Rebekah G. Langston
07:00 AM - 05:00 PM EDT Abstract 150 - Parkinson’s Disease Burden by Hoehn and Yahr Stage Using Real-World Data From the Parkinson’s Outcomes Project
Elisabeth Fine, PhD
07:00 AM - 05:00 PM EDT Abstract 151 - Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Equivalent Levodopa Exposure to Levodopa-Carbidopa Intestinal Gel Delivered to the Jejunum
Matthew Rosebraugh, PhD
07:00 AM - 05:00 PM EDT Abstract 152 - In Vitro Profile of a Novel Long Lasting Dopamine Agonist Designed to Optimize Efficacy and Safety
07:00 AM - 05:00 PM EDT Abstract 153 - Cannabis use in people with Parkinson’s disease: Reported patterns of use, symptomatic benefits, and adverse effects via Fox Insight
Samantha K. Holden, MD, MS, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 154 - Reversible MIBG Abnormalities In subjects at risk for Synucleinopathy
Helia Maghzi, MD
07:00 AM - 05:00 PM EDT Abstract 155 - Quantification of Brain Iron Accumulation in Different Stages of Parkinson’s Disease Using Quantitative Susceptibility Mapping (QSM)
Kailyn Li
07:00 AM - 05:00 PM EDT Abstract 156 - The Role of White Matter Hyperintensities in Parkinson’s Disease Progression and Outcome
Edoardo G. Spinelli, MD
07:00 AM - 05:00 PM EDT Abstract 157 - Gait correlates of resting-state functional connectivity of cerebellar vermis in Parkinson disease.
Baijayanta Maiti, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 158 - Hippocampal subfield volumetry for predicting cognitive impairment in Parkinson’s disease
Niels Bergsland
07:00 AM - 05:00 PM EDT Abstract 159 - A Study of Optical Coherence Tomography and its Correlation with Clinical Severity in Idiopathic Parkinson’s Disease
Butchi Raju Garuda, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 160 - Functional Connectivity as an Early Marker of Indication for Deep Brain Stimulation Treatment in Parkinson’s Disease
Luigi Albano, MD
07:00 AM - 05:00 PM EDT Abstract 161 - Longitudinal Structural Brain Alterations in Parkinson’s Disease Patients with Freezing of Gait
Noemi Piramide, MSc
07:00 AM - 05:00 PM EDT Abstract 162 - Role of Dopamine Transporter Scan (DaTscan) imaging in the Evaluation of Parkinsonism: Experience from a Tertiary Care Center
Deepmala Nandanwar, MD
07:00 AM - 05:00 PM EDT Abstract 163 - Functional MRI Connectivity of the Primary Motor Cortex in Functional Dystonia Patients
Noemi Piramide, MSc
07:00 AM - 05:00 PM EDT Abstract 164 - Immune-mediated movement disorders: clinical manifestations, treatment, and evolution. A multicenter study
07:00 AM - 05:00 PM EDT Abstract 166 - Nilotinib significantly alters miRNAs that control genes of the inflammatory, bioenergetics and transport pathways in the CSF of Parkinson’s patients
Yasar A. Torres-Yaghi, MD
07:00 AM - 05:00 PM EDT Abstract 167 - Assessment of a Novel Long Lasting Dopamine Agonist in the Unilateral 6-OHDA Lesion Model of Parkinson’s Disease
07:00 AM - 05:00 PM EDT Abstract 168 - Case Report: Painful leg spasms in patient with hemifacial spasms and Vitamin D and vitamin B12 deficiency
Julius B. Anang, MD, PhD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 169 - Telemedicine Satisfaction in Patients With Movement Disorders
Yamil Matuk Perez, MD
07:00 AM - 05:00 PM EDT Abstract 170 - Atypical presentation of Ataxia telangiectasia masquerading as Parkinson’s Disease
Gabriella P. Casinelli, MD
07:00 AM - 05:00 PM EDT Abstract 171 - Non-Ketotic Hyperglycemic Hemichorea/Hemiballism
Tarek E. Ali, MBBS
07:00 AM - 05:00 PM EDT Abstract 172 - Acute-Onset Parkinsonism Secondary To Bilateral Extrapontine Myelinolysis Of The Basal Ganglia: A Case Report.
Brenda Bertado, MD
07:00 AM - 05:00 PM EDT Abstract 173 - Association between Microscopic Colitis and Parkinson's Disease in a Swedish Population
Xiaoying Kang
07:00 AM - 05:00 PM EDT Abstract 174 - Towards defining the Parkinson’s health-ome
Abby L. Olsen, MD
07:00 AM - 05:00 PM EDT Abstract 175 - Association of Medication Mismanagement with Hospital-Related Complications in Patients with Parkinson’s Disease at The George Washington University Hospital (GWUH)
Christina Kallik, MD
07:00 AM - 05:00 PM EDT Abstract 176 - Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-based Study (2010-2015)
Emanuele Camerucci, MD
07:00 AM - 05:00 PM EDT Abstract 177 - Unmet needs and treatment patterns of advanced Parkinson’s Disease patients in the United States
Irene Malaty, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 178 - Chronic Comorbidities of Caregivers of Homebound Individuals with Advanced Parkinson’s Disease
Jori Fleisher, MD, MSCE, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 179 - Treatment Patterns in a Real-World Sample of Patients with Parkinson’s Disease and Motor Fluctuations
Robert A. Hauser, MD, MBA, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 180 - Clinical Predictors of Underlying Neurodegeneration in Drug-Induced Parkinsonism
Whitley W. Aamodt, MD
07:00 AM - 05:00 PM EDT Abstract 181 - The Implications of Upper Motor Neuron Burden in Multiple System Atrophy
Sheng-Han Kuo, MD, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 182 - M-STAR, An Ongoing Phase 3 Study in Participants with Multiple System Atrophy–Baseline Characteristics
Irfan Qureshi, MD
07:00 AM - 05:00 PM EDT Abstract 183 - Essential Tremor Followed by Progressive Supranuclear Palsy: A Postmortem Series of Seven Additional Cases
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 184 - Vertical Pseudonystagmus In Progressive Supranuclear Palsy
Hemani Ticku, MD
07:00 AM - 05:00 PM EDT Abstract 185 - Prognosis and preferences for communication about end-of-life care in atypical parkinsonism
Gerard Raimon Saranza, MD
07:00 AM - 05:00 PM EDT Abstract 186 - Corticobasal Degeneration and Auditory Hallucination: A Case Report
Chi-Ying (Roy) Lin, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Whitley W. Aamodt, MD Dr. Aamodt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Michael S. Okun, MD, FÂ鶹´«Ã½Ó³»­ Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Rahila Ansari, MD Dr. Ansari has received personal compensation in the range of $0-$499 for serving as a Course Director with Â鶹´«Ã½Ó³»­.
No disclosure on file
Aldina Imamovic Aldina Imamovic has nothing to disclose.
Bryan A. Bernard, PhD Dr. Bernard has nothing to disclose.
Cristian Calandra, MD Dr. Calandra has nothing to disclose.
Lakshmi N. Ranganathan, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Ranganathan has nothing to disclose.
Maria C. Ospina, MD Dr. Ospina has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for US World Meds. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sunovian. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kywoa Kirin. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Ospina has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ospina has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovian. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Ospina has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Ospina has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ospina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US World Meds.
Richard M. Trosch, MD, FÂ鶹´«Ã½Ó³»­ Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal . Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine . Dr. Trosch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Fei Wang, PhD Fei Wang, PhD has received personal compensation for serving as an employee of Stoke Therapeutics.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Angelo Antonini, MD Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Benjamin L. Walter, MD Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott.
Sharlet Anderson, PhD Dr. Anderson has nothing to disclose.
Risa Isonaka Risa Isonaka has nothing to disclose.
Gerard Raimon Saranza, MD Dr. Saranza has nothing to disclose.
Joseph E. Malone, MD Dr. Malone has nothing to disclose.
Abby L. Olsen, MD An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Rheos Medicines. An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Novasenta. An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Biohaven. The institution of Dr. Olsen has received research support from NINDS. The institution of Dr. Olsen has received research support from DoD. The institution of Dr. Olsen has received research support from American Parkinson's Disease Association. The institution of Dr. Olsen has received research support from Alzheimer's Association.
Fernando L. Pagan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Collin J. Anderson, PhD The institution of Dr. Anderson has received research support from National Ataxia Foundation. The institution of Dr. Anderson has received research support from NIH. The institution of an immediate family member of Dr. Anderson has received research support from NIH. The institution of an immediate family member of Dr. Anderson has received research support from University of Utah.
Raghav Govindarajan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Gabriella P. Casinelli, MD Dr. Casinelli has nothing to disclose.
Sol T. De Jesus, MD Dr. De Jesus has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic Inc. Dr. De Jesus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc.
Deena M. Kegler-Ebo, PhD Dr. Kegler-Ebo has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Kegler-Ebo has received stock or an ownership interest from Acorda Therapeutics.
Brenda Bertado, MD No disclosure on file
Yamil Matuk Perez, MD Dr. Matuk Perez has nothing to disclose.
Vicki L. Wheelock, MD Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME Continuing Medical Â鶹´«Ã½Ó³»­.
Thomas L. Davis, MD Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinson Foundation.
Kelly L. Block, DO Dr. Block has nothing to disclose.
José David García Romero Mr. García Romero has nothing to disclose.
Elizabeth A. Coon, MD, FÂ鶹´«Ã½Ó³»­ Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Pinky H. Agarwal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Erin Furr-Stimming, MD, FÂ鶹´«Ã½Ó³»­ Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from HDSA. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with Â鶹´«Ã½Ó³»­ UES Committee that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Maurizio Facheris, MD, MSc Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has or had stock in Vanqua Bio.
Owen A. Ross, PhD Dr. Ross has nothing to disclose.
Irene Malaty, MD, FÂ鶹´«Ã½Ó³»­ Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Lucrecia Bandeo Lucrecia Bandeo has nothing to disclose.
Elisabetta Sarasso Elisabetta Sarasso has nothing to disclose.
Aminah Abdul Razzack Ms. Abdul Razzack has nothing to disclose.
Navpreet K. Bains, DO Dr. Bains has nothing to disclose.
Chandrasekhar Kasibhatla No disclosure on file
Noemi Piramide, MSc Noemi Piramide has nothing to disclose.
Meredith Bock, MD The institution of Dr. Bock has received research support from Â鶹´«Ã½Ó³»­. The institution of Dr. Bock has received research support from Michael J Fox Foundation.
Daniel A. Crespo, MD Dr. Crespo has nothing to disclose.
Echo Tan, MD Dr. Tan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan.
Andrea Kuehn Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Burkhard Blank Burkhard Blank has received personal compensation for serving as an employee of Acorda Therapeutics. Burkhard Blank has received stock or an ownership interest from Acorda Therapeutics, Inc.
Phyllis Faust Phyllis Faust has nothing to disclose.
Svjetlana Miocinovic, MD, PhD Dr. Miocinovic has nothing to disclose.
David S. Goldstein, MD, PhD Dr. Goldstein has received publishing royalties from a publication relating to health care.
Camilla Kilbane, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for acorda. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbvie. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kyowa kirin. Dr. Kilbane has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medronic. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for US world Meds. Dr. Kilbane has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Kilbane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Kilbane has received research support from Abbott.
Mark C. Stahl, MD, PhD Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
Aaron S. Kemp, PhD Aaron Kemp has nothing to disclose.
Raymond Rosales Dr. Rosales has nothing to disclose.
Parizad Varghaei, MD Parizad Varghaei has nothing to disclose.
Kiley Cameron, MD Dr. Cameron has nothing to disclose.
Daniel Bandari, MD The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Iva Stankovic Iva Stankovic has nothing to disclose.
Tal Birnberg Tal Birnberg has received personal compensation for serving as an employee of Neuroderm.
Niodita R. Gupta, MD, PhD, MPH Dr. Gupta has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Gupta has received stock or an ownership interest from AbbVie Inc..
Leslie Citrome Leslie Citrome has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for AbbVie, Acadia, Alkermes, Allergan, Avanir, BioXcel, Cadent Therapeutics, Eisai, Impel, Intra-Cellular Therapies, Janssen, Lundbeck, Luye, Merck, Neurocrine, Noven, Osmotica, Otsuka, Sage, Shire, Sunovion, Takeda, Teva. Leslie Citrome has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for AbbVie, Acadia, Alkermes, Allergan, Eisai, Intra-Cellular Therapies, Janssen, Lundbeck, Merck, Neurocrine, Noven, Otsuka, Sage, Shire, Sunovion, Takeda, Teva. Leslie Citrome has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley, Elsevier. Leslie Citrome has stock in Bristol-Myers Squibb, Eli Lilly, J & J, Merck, Pfizer . Leslie Citrome has received publishing royalties from a publication relating to health care.
Hector Tellez Mr. Tellez has nothing to disclose.
Inge Meijer, MD, PhD Dr. Meijer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Meijer has received intellectual property interests from a discovery or technology relating to health care.
Aaron Ritter, MD The institution of Dr. Ritter has received research support from NIH.
Atul T. Patel Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
Oscar Martinez, MD No disclosure on file
Kristina M. Fanning, PhD The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Nahome Fisseha Nahome Fisseha has received personal compensation for serving as an employee of AbbVie. Nahome Fisseha has received stock or an ownership interest from AbbVie.
Sushma Kola, MD Dr. Kola has nothing to disclose.
Enrique Urrea-Mendoza, MD Dr. Urrea-Mendoza has nothing to disclose.
Wei Liu Wei Liu has received personal compensation for serving as an employee of AbbVie. Wei Liu has received stock or an ownership interest from AbbVie.
Deborah H. Hall, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Nasrin E. Moin, DNP, CNS, NP-C Ms. Esnaashari has nothing to disclose.
Eric Pappert Eric Pappert has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Aasef Shaikh, MD Dr. Shaikh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Zeyang Yu, PhD Dr. Yu has received research support from NIH.
Johannes R. Streffer, MD Dr. Streffer has received personal compensation for serving as an employee of H. Lundbeck A/S. Dr. Streffer has or had stock in H. Lundbeck A/S.
Rodolfo Savica, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Lisa M. Shulman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Oscar Esquivel, MD Mr. Esquivel has nothing to disclose.
David A. Stamler, MD Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
Matthew Rosebraugh, PhD Dr. Rosebraugh has received personal compensation for serving as an employee of AbbVie Inc. Dr. Rosebraugh has stock in AbbVie Inc..
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Shrivarthan R Mr. R has nothing to disclose.
Katherine D. Amodeo, MD The institution of Dr. Amodeo has received research support from Roche. The institution of Dr. Amodeo has received research support from EIP Pharma. The institution of Dr. Amodeo has received research support from Acadia. The institution of Dr. Amodeo has received research support from MJFF. The institution of Dr. Amodeo has received research support from NINDS.
Yongjie Li No disclosure on file
Xiao-Yu Lu Xiao-Yu Lu has received personal compensation for serving as an employee of Genentech.
Michael Althaus Michael Althaus has received personal compensation for serving as an employee of Merz Pharmaceuticals.
Alexandra Tomic No disclosure on file
Irfan Qureshi, MD Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Margaret Bradbury Margaret Bradbury has received personal compensation for serving as an employee of Alterity Therapeutics. The institution of Margaret Bradbury has received research support from Alterity Therapeutics.
Tyler J. Allison, MD, FÂ鶹´«Ã½Ó³»­ Dr. Allison has nothing to disclose.
Paul Gilbert, PhD Dr. Gilbert has nothing to disclose.
Roy Alcalay, MD Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Holly Roberts, MD No disclosure on file
Ann Murray, MD Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Mayela D. Rodriguez Violante, MD Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rodriguez Violante has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sandoz Novartis. Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zydus. The institution of Dr. Rodriguez Violante has received research support from LARGE-PD.
Helia Maghzi, MD Dr. Maghzi has nothing to disclose.
Imen Kacem, MD Dr. Kacem has nothing to disclose.
Lakshmi Pillai Ms. Pillai has nothing to disclose.
Nutan Sharma, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Sharma has nothing to disclose.
Jorge Gustavo Jose Jorge Gustavo Jose has received personal compensation for serving as an employee of hospital padilla. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis, . Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving as a Consultant for RAFFO. Jorge Gustavo Jose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Jorge Gustavo Jose has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Jorge Gustavo Jose has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MERCK. Jorge Gustavo Jose has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ROCHE. The institution of Jorge Gustavo Jose has received research support from NOVARTIS. Jorge Gustavo Jose has received research support from ROCHE. Jorge Gustavo Jose has received research support from SANOFI.
Florita Valiñas No disclosure on file
R Arturo Abundes-Corona, MD Dr. Abundes-Corona has nothing to disclose.
Criscely Go, MD Dr. Go has nothing to disclose.
Domenico Vitarella No disclosure on file
Jennifer S. Hui, MD Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Hui has received research support from Roche. The institution of Dr. Hui has received research support from Abbvie. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Roundtable speaker with Medscape .
Diana Slowiejko Diana Slowiejko has received personal compensation for serving as an employee of Genentech Inc.
Mered Parnes, MD Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Omar Ladhani Omar Ladhani has received personal compensation for serving as an employee of AbbVie. Omar Ladhani has received stock or an ownership interest from AbbVie.
Jinnie Ko Jinnie Ko has received personal compensation for serving as an employee of Genentech.
Alan Fowler Mr. Fowler has nothing to disclose.
Elliot J. Hogg, MD Dr. Hogg has nothing to disclose.
Pedro Gonzalez-Alegre, MD Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuExcell. The institution of Dr. Gonzalez-Alegre has received research support from NIH/NINDS. Dr. Gonzalez-Alegre has received intellectual property interests from a discovery or technology relating to health care.
Mariana Gandelman, PhD Dr. Gandelman has received research support from NINDS.
Claudia Testa, MD, PhD Dr. Testa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Tremor Research Group.
Nicolas Dupre, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Helio Afonso G. Teive, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Teive has nothing to disclose.
Alberto Esquenazi, MD Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Demetrius M. Maraganore, MD, FÂ鶹´«Ã½Ó³»­ Dr. Maraganore has nothing to disclose.
Mohammed Qureshi, MD Dr. Qureshi has nothing to disclose.
Amina Nasri, MD Dr. Nasri has nothing to disclose.
Lauren Jackson, MD Dr. Jackson has nothing to disclose.
Debra J. Ehrlich, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ehrlich has nothing to disclose.
Richard Walsh, MD Dr. Walsh has nothing to disclose.
Emanuele Camerucci, MD Dr. Camerucci has nothing to disclose.
Robin A. Elkins, NP Mrs. Elkins has nothing to disclose.
Drew S. Kern, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Aleksej Zuzek, PhD Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc..
Thyagarajan Subramanian, MD, MBBS, FÂ鶹´«Ã½Ó³»­ Dr. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Subramanian has received research support from National Institutes of Health. The institution of Dr. Subramanian has received research support from Ann and Phillip Gladfetler III Foundation. The institution of Dr. Subramanian has received research support from Department of Defense . Dr. Subramanian has received publishing royalties from a publication relating to health care. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Deepal P. Shah-Zamora, MD Dr. Shah-Zamora has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Winthrop Industrie. The institution of Dr. Shah-Zamora has received research support from CereGate Inc. The institution of Dr. Shah-Zamora has received research support from Amneal. The institution of Dr. Shah-Zamora has received research support from AbbVie .
Cynthia L. Comella, MD, FÂ鶹´«Ã½Ó³»­ Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Peter Karachunski, MD Dr. Karachunski has nothing to disclose.
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Rashid Kazerooni Rashid Kazerooni has received personal compensation for serving as an employee of Merz Therapeutics.
Grisel J. Lopez, MD Dr. Lopez has nothing to disclose.
Diego Ballesteros No disclosure on file
Susmit Tripathi, MD Dr. Tripathi has nothing to disclose.
Stephen J. Howell, BS, EMT-B Mr. Howell has nothing to disclose.
Mario P. Zamora Dr. Zamora has nothing to disclose.
John McCarron John McCarron has nothing to disclose.
Robert G. Holloway, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Holloway has nothing to disclose.
Maureen Leehey, MD, FÂ鶹´«Ã½Ó³»­ Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research and Consulting. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Leehey has received personal compensation in the range of $0-$499 for serving as a Consultant for Sphenix Global Insight. Dr. Leehey has received personal compensation in the range of $0-$499 for serving as a Consultant for Olson Research Group. The institution of Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris Medicine. The institution of Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huron Consulting Services. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zynerba. The institution of Dr. Leehey has received research support from Michael J Fox Foundation. The institution of Dr. Leehey has received research support from Colorado Dept of Public Health and Environment. The institution of Dr. Leehey has received research support from Biogen. The institution of Dr. Leehey has received research support from US World Meds. The institution of Dr. Leehey has received research support from Vtesse. The institution of Dr. Leehey has received research support from NeuroDerm. The institution of Dr. Leehey has received research support from Denali. The institution of Dr. Leehey has received research support from Neuraly. The institution of Dr. Leehey has received research support from NINDS.
Sherrie E. Gould, NP Mrs. Gould has nothing to disclose.
Vladimir S. Kostic, MD, PhD Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of Â鶹´«Ã½Ó³»­, Science and Technological Development of Serbia.
Sarah Ingersoll, RN, PHN Ms. Ingersoll has nothing to disclose.
Roman Rubio Roman Rubio has received personal compensation for serving as an employee of Revance.
Tomoko Arakaki No disclosure on file
Adrienne Visani Ms. Visani has nothing to disclose.
Anhar Hassan, MBBCH, FRACP, FRCPI, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Yasar A. Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Sarah H. Ying, MD Dr. Ying has nothing to disclose.
Luis Pellene Luis Pellene has nothing to disclose.
Amanda Wilhelm Amanda Wilhelm has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Shannon Y. Chiu, MD, MSc Dr. Chiu has received research support from NIH.
Daniella Pinto Ms. Pinto has nothing to disclose.
John M. Bertoni, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bertoni has nothing to disclose.
David G. Standaert, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Pharmacy. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffman LaRoche. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from National Institutes of Health. The institution of Dr. Standaert has received research support from F. Hoffman LaRoche. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Joel S. Perlmutter, MD, FÂ鶹´«Ã½Ó³»­ Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CHDI. Dr. Perlmutter has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Study Group. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Cooper and Peterson, LLC . Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Simmons and Simmons LLP . The institution of Dr. Perlmutter has received research support from NIH. The institution of Dr. Perlmutter has received research support from American Parkinson Disease Association (Advanced Research Center at Washington University). The institution of Dr. Perlmutter has received research support from CHDI. The institution of Dr. Perlmutter has received research support from Huntington Disease Society of America. The institution of Dr. Perlmutter has received research support from University of Western Toronto. The institution of Dr. Perlmutter has received research support from Barnes-Jewish Hospital Foundation. The institution of Dr. Perlmutter has received research support from Michael J Fox Foundation. The institution of Dr. Perlmutter has received research support from UCSD. The institution of Dr. Perlmutter has received research support from Paula & Rodger Riney FUnd. The institution of Dr. Perlmutter has received research support from Jo Oertli Fund. The institution of Dr. Perlmutter has received research support from Murphy FUnd. The institution of Dr. Perlmutter has received research support from Fixel Fund. The institution of Dr. Perlmutter has received research support from N Grant WIlliams Fund. The institution of Dr. Perlmutter has received research support from Pohlman Fund. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Boston University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a external advisor with Stanford University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with Beth Israel Hospital. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with U Pennsylvania.
Lilly Chen Lilly Chen has received personal compensation for serving as an employee of Boston Scientific .
Yarema Bezchlibnyk Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PMT Inc. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbott. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Yarema Bezchlibnyk has received research support from Medtronic.
George M. Plotkin, MD, PhD The institution of Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic.
Neel Fotedar, MD Dr. Fotedar has received research support from NINDS.
Pavnit Kukreja, PharmD Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
Silvia Basaia Silvia Basaia has nothing to disclose.
Alfredo H. Laffue, MD Dr. Laffue has nothing to disclose.
Diego Torres-Russotto, MD, FÂ鶹´«Ã½Ó³»­ Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Mark Hallett, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Marco A. Munuzuri Mr. Munuzuri has nothing to disclose.
Antoine Duquette, MD Dr. Duquette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. The institution of Dr. Duquette has received research support from Actelion. The institution of Dr. Duquette has received research support from Ataxia Canada/FARA.
Ellen Sidransky, MD The institution of Dr. Sidransky has received research support from mjff. The institution of Dr. Sidransky has received research support from Roche.
Mohammad Ikram The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Aidan Mullan Aidan Mullan has nothing to disclose.
Samuel A. Frank, MD, FÂ鶹´«Ã½Ó³»­ Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
Marcela Uribe Roca The institution of Marcela Uribe Roca has received research support from Roche.
Allison Wright Willis, MD Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Yash Jalundhwala, PhD Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . An immediate family member of Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . Dr. Jalundhwala has received stock or an ownership interest from AbbVie.
Ping Zhuang, PhD Dr. Zhuang has nothing to disclose.
Jose M. Trejo, MD No disclosure on file
Ann E. Corbin, DHSc, MS Dr. Corbin has received personal compensation for serving as an employee of Ipsen Biopharmaceuticals. Dr. Corbin has or had stock in Ipsen Biopharmaceuticals .
Kenneth Hayashida Kenneth Hayashida has nothing to disclose.
Stella Jensen-Roberts Ms. Jensen-Roberts has nothing to disclose.
Felixe Pelletier, MD Dr. Pelletier has nothing to disclose.
Robert Ristuccia, PhD No disclosure on file
Ryuji Kaji, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaji has nothing to disclose.
Francisco Caiza Zambrano, MD Dr. Caiza Zambrano has nothing to disclose.
Joseph Silva Mr. Silva has received research support from Rush Medical College Alumni Association.
Paul Beach, DO, PhD Dr. Beach has received personal compensation in the range of $0-$499 for serving as a Consultant for BGB Group. Dr. Beach has received personal compensation in the range of $0-$499 for serving as a Consultant for Theravance Biopharma. Dr. Beach has received research support from National Institutes of Health. Dr. Beach has received research support from National Institutes of Health. Dr. Beach has a non-compensated relationship as a Director at Large with Mission MSA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Stewart A. Factor, DO, FÂ鶹´«Ã½Ó³»­ Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Diogo Magalhães Diogo Magalhães has received personal compensation for serving as an employee of BIAL.
Stefan Sillau Stefan Sillau has nothing to disclose.
Xiaoye Ma Xiaoye Ma has received personal compensation for serving as an employee of Genentech.
Lin Zhang, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for supernus. Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for supernus. The institution of Dr. Zhang has received research support from Michael J. Fox Foundation.
Alex Exuzides Alex Exuzides has nothing to disclose.
Andrew D. Siderowf, MD Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Steven Ojemann The institution of Steven Ojemann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alpha omega engineering. The institution of Steven Ojemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kenai Therapeutics. Steven Ojemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Insightec. Steven Ojemann has stock in Phasor inc.
Saumel B. Ahmadi, MD, PhD Dr. Ahmadi has received intellectual property interests from a discovery or technology relating to health care. Dr. Ahmadi has received intellectual property interests from a discovery or technology relating to health care.
Farwa Ali, MD Dr. Ali has nothing to disclose.
Walter O. Arruda, MD, PhD Dr. Arruda has nothing to disclose.
Tiago Mestre, MD, MSC Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CHDI. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mestre has received research support from CIHR. The institution of Dr. Mestre has received research support from Ontario Research Fund. The institution of Dr. Mestre has received research support from MJFF. The institution of Dr. Mestre has received research support from Parkinson Canada. The institution of Dr. Mestre has received research support from University of Ottawa/PRC.
Tove Henriksen, MD Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nordic infucare. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Britannia. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for convatec. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nordic Infucare. Dr. Henriksen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia.
John E. Duda, MD Dr. Duda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Publishing Group. The institution of Dr. Duda has received research support from Department of Veterans Affairs. The institution of Dr. Duda has received research support from Michael J. Fox Foundation. The institution of Dr. Duda has received research support from Innervace, Incorporated. The institution of Dr. Duda has received research support from National Institutes of Health.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Martin Mwangi, MD Dr. Mwangi has nothing to disclose.
Maria Camila Moreno Escobar, MD Dr. Moreno Escobar has nothing to disclose.
Richa Tripathi, MD Dr. Tripathi has nothing to disclose.
Humberto Leal Bailey, MD Dr. Leal Bailey has nothing to disclose.
Nayla Chaijale Nayla Chaijale has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Weining Robieson, PhD Dr. Robieson has received personal compensation for serving as an employee of AbbVie. Dr. Robieson has received stock or an ownership interest from AbbVie.
Patrick Acuna Mr. Acuna has nothing to disclose.
Tarek E. Ali, MBBS Dr. Ali has nothing to disclose.
Faical Isbaine Faical Isbaine has received personal compensation for serving as an employee of Dixi Medical.
Alana E. Kirby, MD, PhD The institution of Dr. Kirby has received research support from National Institutes of Health. The institution of Dr. Kirby has received research support from Cohn Family. The institution of Dr. Kirby has received research support from Postma Family.
Travis Larsh, MD Dr. Larsh has nothing to disclose.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Hemani Ticku, MD Dr. Ticku has nothing to disclose.
Harini Sarva, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Marissa N. Dean, MD The institution of Dr. Dean has received research support from Hoffman-La Roche. The institution of Dr. Dean has received research support from Vaccinex Inc.. The institution of Dr. Dean has received research support from Abbvie, Inc.. The institution of Dr. Dean has received research support from Retrophin, Inc.. The institution of Dr. Dean has received research support from Annexon, Inc.. The institution of Dr. Dean has received research support from Neurocrine Biosciences. The institution of Dr. Dean has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Dean has received research support from CHDI Foundation. The institution of Dr. Dean has received research support from Eli Lily and Company. The institution of Dr. Dean has received research support from United States Army Medical Research and Development Command. The institution of Dr. Dean has received research support from UniQure Biopharma B.V.. The institution of Dr. Dean has received research support from Neuraly, Inc.. The institution of Dr. Dean has received research support from Praxis Precision Medicines.
Stefan Wietek, PhD Dr. Wietek has received personal compensation for serving as an employee of Ipsen.
Mark F. Gordon, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
Sarah Farias No disclosure on file
Un J. Kang, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kang has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Experimental Neurology. The institution of Dr. Kang has received research support from NIH. The institution of Dr. Kang has received research support from Parkinson's Foundation. The institution of Dr. Kang has received research support from Michael J Fox Foundation for Parkinson's Research.
Paul M. Bourgeois, MD Dr. Bourgeois has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE.
Ruth Schneider, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from Bial. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Saira Saad, MBBS Saira Saad has nothing to disclose.
Fernando Cubillos Mr. Cubillos has nothing to disclose.
Rebekah G. Langston Ms. Langston has nothing to disclose.
Esther Cubo Delgado, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Poornima Jayadev Menon, MbBchBAO, MRCPI The institution of Dr. Jayadev Menon has received research support from Michael J Fox Foundation.
George F. Wittenberg, MD, PhD The institution of Dr. Wittenberg has received research support from Deptment of Veterans Affairs.
Yanjun Bao, PhD Ms. Bao has received personal compensation for serving as an employee of AbbVie.
Sarah J. Doss, MD Dr. Doss has nothing to disclose.
Steven Kymes Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Natalie P. Witek, MD Dr. Witek has nothing to disclose.
Thanh Nguyen No disclosure on file
Sam Leo, PharmD Dr. Leo has received personal compensation for serving as an employee of Teva Pharmaceutical Industries.
Kulwant Bhatia Kulwant Bhatia has received personal compensation for serving as an employee of Medtronic.
Samir S. Al-Ghazawi, MD Dr. Al-Ghazawi has nothing to disclose.
June Yin, MD No disclosure on file
Ziv Gan-Or, MD, PhD Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Cole D. Stang Mr. Stang has nothing to disclose.
Dhira Khosla, DO Dr. Khosla has received personal compensation for serving as an employee of Cala Health. Dr. Khosla has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cala Health.
Rajeev Kumar, MD, FRCPC The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevance. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ferrer. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. Dr. Kumar has stock in Neurofold Therapeutics. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. The institution of Dr. Kumar has received research support from Aribio. The institution of Dr. Kumar has received research support from Biogen. The institution of Dr. Kumar has received research support from Bial R and D investments. The institution of Dr. Kumar has received research support from Ono Pharmaceutical Company. The institution of Dr. Kumar has received research support from UCB Biopharma. The institution of Dr. Kumar has received research support from Vigil Therapeutics. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC. Dr. Kumar has a non-compensated relationship as a Board Member with Movement Disorders Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Venugopalan Y. Vishnu, MD The institution of Dr. Vishnu has received research support from Department of Health Research.
Stuart H. Isaacson, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Alejandro Kohler No disclosure on file
Vikram Shivkumar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Muhammad W. Anjum, MD Dr. Anjum has nothing to disclose.
Pritha T. Ghosh, MD Dr. Ghosh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for New Touch Digital.
Tetsuo Ashizawa, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Blanca Y. Valdovinos, MD Dr. Valdovinos has nothing to disclose.
Alvaro Garcia Bustillo Alvaro Garcia Bustillo has nothing to disclose.
Zhaoxia Wang, DO No disclosure on file
Roshini Jain Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Osnat Ehrman Ms. Ehrman has received personal compensation for serving as an employee of Neuroderm.
Paula C. Azevedo, MD Dr. Azevedo has nothing to disclose.
Sebastien Audet Mr. Audet has nothing to disclose.
Andrea Formella, PharmD, BCPP Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..
Robert Fishman, MD Dr. Fishman has nothing to disclose.
Anthony E. Lang, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Nelida Garretto, MD No disclosure on file
Andrea C. Adams, MD Dr. Adams has nothing to disclose.
Lisanne Dommershuijsen Lisanne Dommershuijsen has nothing to disclose.
Jason L. Aldred, MD, FÂ鶹´«Ã½Ó³»­ Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $0-$499 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from NeuroDerm. The institution of Dr. Aldred has received research support from PhotoPharma. The institution of Dr. Aldred has received research support from Lilly. Dr. Aldred has received research support from Capsida Biotherapeutics. Dr. Aldred has received research support from Teva. Dr. Aldred has received research support from Lundbeck. Dr. Aldred has received research support from Denali Therapeutics. Dr. Aldred has received research support from Intra-Cellular Therapies Inc.. Dr. Aldred has received research support from Vima Therapeutics. Dr. Aldred has received research support from Ventus Therapeutics. Dr. Aldred has received research support from Scion NeuroStim .
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Sven Stodtmann No disclosure on file
James T. Boyd, MD Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroDerm . Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InTrance. Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson Study Group . The institution of Dr. Boyd has received research support from NIA/NIH. The institution of Dr. Boyd has received research support from Biotie . The institution of Dr. Boyd has received research support from vaccinex. The institution of Dr. Boyd has received research support from CHDI. The institution of Dr. Boyd has received research support from AbbVie. The institution of Dr. Boyd has received research support from Roche . The institution of Dr. Boyd has received research support from Revance . The institution of Dr. Boyd has received research support from NeuroDerm. The institution of Dr. Boyd has received research support from Neurocrine .
Sean T. Kenniff, MD Dr. Kenniff has nothing to disclose.
Mariam Hull, MD Dr. Hull has received publishing royalties from a publication relating to health care.
Fedor Panov Fedor Panov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. Fedor Panov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for zimmer biomet.
Jayne R. Wilkinson, MD, MSCE Dr. Wilkinson has nothing to disclose.
Lakshmi Arbatti, NLP Mrs. Arbatti has received personal compensation for serving as an employee of Grey Matter Technologies, LLC.
Hesham A. Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Richard R. Murphy, MBChB, FÂ鶹´«Ã½Ó³»­ Dr. Murphy has nothing to disclose.
Camilla Cividini, MSc Ms. Cividini has nothing to disclose.
Ihtsham Haq, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Elka Stefanova No disclosure on file
Jamie Ta Jamie Ta has received personal compensation for serving as an employee of Genentech.
Stefan M. Pulst, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Baijayanta Maiti, MD, PhD The institution of Dr. Maiti has received research support from National Center for Advancing Translational Sciences of the NIH . The institution of Dr. Maiti has received research support from National Institute of Neurological Disorders and Stroke (NINDS) / NIH .
Jody Corey-Bloom, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Chi-Ying (Roy) Lin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Mya C. Schiess, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schiess has nothing to disclose.
Neepa J. Patel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernius Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Jacquelyn L. Bainbridge, MD The institution of Dr. Bainbridge has received research support from CDPHE. The institution of Dr. Bainbridge has received research support from CDPHE.
Grace M. Tabatabai, MD Dr. Tabatabai has nothing to disclose.
Steven W. Nakano, MD Dr. Nakano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin Group. Dr. Nakano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals.
Daniel R. Scoles, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Scoles has received research support from NIH.
Shannon Doerhoff, NP Shannon Doerhoff has nothing to disclose.
Addie Patterson, DO Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Medical insights group.
Alfonso Fasano, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Jack Wright Jack Wright has received personal compensation for serving as an employee of Adelphi Real World.
Lorraine Cuffe Lorraine Cuffe has received personal compensation for serving as an employee of Ipsen.
Glenn T. Stebbins, PhD Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Karen E. Anderson Ms. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for teva. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Biogen. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ms. Anderson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for neurocrine. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medscape. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for atheneum. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GLG. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with CHDI.
Jessica K. Alexander, PhD Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Saleem M. Al Mawed, MD Dr. Al Mawed has nothing to disclose.
Marta Banach, MD Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Merz Pharmaceuticals GmbH.
Joseph Jankovic, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Meagan O. Bailey, MD Dr. Bailey has nothing to disclose.
Ka Loong K. Au, MD Dr. Au has nothing to disclose.
Yazmin Rios-Solis No disclosure on file
Thanh Phuong Pham Nguyen, PharmD, MBA, MSCE The institution of Dr. Pham Nguyen has received research support from National Institute of Health. The institution of Dr. Pham Nguyen has received research support from National Institute of Health.
Alexander Shtilbans, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Shtilbans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Medicine. Dr. Shtilbans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals. Dr. Shtilbans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Shtilbans has received research support from Praxis Medicine.
Ann H. Tilton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date.
Jorge D. Amor, MD Jorge Amor has nothing to disclose.
Kailyn Li Ms. Li has nothing to disclose.
Charlotte Wahle Charlotte Wahle has nothing to disclose.
Amputch Karukote, MD Dr. Karukote has nothing to disclose.
Massimo Filippi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Dietrich Haubenberger, MD, FÂ鶹´«Ã½Ó³»­ Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Ruta Deshpande Ruta Deshpande has nothing to disclose.
Chadwick W. Christine, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Christine has received research support from Michael J Fox Foundation for Parkinson's Research. The institution of Dr. Christine has received research support from Aspen Neurosciences. The institution of Dr. Christine has received research support from ASK BIo. The institution of Dr. Christine has received research support from Bayer.
Aparna Wagle-Shukla, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Lee E. Neilson, MD Dr. Neilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hart Wagner LLP. Dr. Neilson has received research support from VA ORD - Clinical Science Research and Development. An immediate family member of Dr. Neilson has received research support from NIH - NINDS.
Leonardo Almeida No disclosure on file
Niels Bergsland Prof. Bergsland has nothing to disclose.
Mai Yamakawa, MD Dr. Yamakawa has nothing to disclose.
Sotirios A. Parashos, MD, PhD Dr. Parashos has received stock or an ownership interest from Abbott. Dr. Parashos has received research support from Park Nicollet Health Services. Dr. Parashos has received publishing royalties from a publication relating to health care.
Jovana Lubarda Jovana Lubarda has nothing to disclose.
Henry P. Moore, MD Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Karla P. Figueroa Ms. Figueroa has nothing to disclose.
Jonathan Carlson No disclosure on file
Clemens R. Scherzer, MD Dr. Scherzer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Scherzer has received research support from NIH. The institution of Dr. Scherzer has received research support from Michael J. Fox Foundation. The institution of Dr. Scherzer has received research support from American Parkinson's Disease Association. Dr. Scherzer has received intellectual property interests from a discovery or technology relating to health care.
Guy A. Rouleau, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Yingnan Han Yingnan Han has received personal compensation for serving as an employee of Sanofi US, Inc..
Jason H. Margolesky, MD, FÂ鶹´«Ã½Ó³»­ Dr. Margolesky has nothing to disclose.
Alfonso Enrique Martinez Nunez, MD Dr. Martinez Nunez has nothing to disclose.
Joohi Jimenez Shahed, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Â鶹´«Ã½Ó³»­. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Olga Klepitskaya, MD, FÂ鶹´«Ã½Ó³»­ Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Klepitskaya has or had stock in Neurocrine Biosciences.
Carlos Rugilo Carlos Rugilo has nothing to disclose.
Ryan R. Walsh, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Walsh has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Walsh has stock in Praxis Precision Medicines.
Joaquim J. Ferreira The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial, Neurocrine, AbbVie, Biogen and Lundbeck. The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, AbbVie, BIAL, Biogen, Lundbeck . The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, BIAL, Nordic Infucare, ONO and SK Chemicals.
Salima Brillman, MD The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cala Health. The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. The institution of Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. The institution of Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for USWorldMeds. Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acadia. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Brillman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for USWorld Meds. Dr. Brillman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Shahnaz Miri, MD Dr. Miri has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Lawfirm. Dr. Miri has or had stock in IATRION.Dr. Miri has received intellectual property interests from a discovery or technology relating to health care.
Samantha K. Holden, MD, MS, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.
Lars Bergmann, MD Dr. Bergmann has received personal compensation for serving as an employee of Abbvie. Dr. Bergmann has or had stock in Abbvie.
Edward R. Dabrowski, MD Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solstice. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alergan. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dabrowski has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Allergan. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Solstice. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alergan. The institution of Dr. Dabrowski has received research support from Ipsen. The institution of Dr. Dabrowski has received research support from Merz.
Zoltan Mari, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ACADIA. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parkinson Study Group. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ACADIA. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Moore and Moore PLLC. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Francis Law Firm PLLC. Dr. Mari has stock in NeuroReserve. Dr. Mari has stock in Sensory Cloud. The institution of Dr. Mari has received research support from Cerevel. The institution of Dr. Mari has received research support from AbbVie. The institution of Dr. Mari has received research support from NIH. The institution of Dr. Mari has received research support from Parkinson's Foundation. The institution of Dr. Mari has received research support from Michael J Fox Foundation. The institution of Dr. Mari has received research support from LBDA. The institution of Dr. Mari has received research support from Eli Lilly.
Lisette Arnaud-Hevi No disclosure on file
Angela Kokkinis Angela Kokkinis has nothing to disclose.
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Ira Shoulson, MD Dr. Shoulson has received research support from Vaccinex.
Brenton A. Wright, MD Dr. Wright has nothing to disclose.
Sheng-Han Kuo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kuo has nothing to disclose.
Manickavasagam Janarthanam, DM No disclosure on file
Susan Fox, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
Kapil D. Sethi, MD, FRCP (UK), FÂ鶹´«Ã½Ó³»­ Dr. Sethi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine.
Ali Alobaidi, PharmD Dr. Alobaidi has received personal compensation for serving as an employee of AbbVie Inc. Dr. Alobaidi has received stock or an ownership interest from AbbVie Inc.
Nabila Dahodwala, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
James H. Bower, MD, MSc, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Bower has received research support from Abbvie.
Joshua Wong, MD The institution of Dr. Wong has received research support from NIH.
Philip W. Tipton, MD Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Mindy K. Bixby, DO The institution of Dr. Bixby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for USWM. The institution of Dr. Bixby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas. Dr. Bixby has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for USWM. Dr. Bixby has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas .
David Devos The institution of Mr. Devos has received research support from Alterity.
Bryan T. Klassen, MD The institution of Dr. Klassen has received research support from Insightec.
Georgia M. Parkin, PhD Georgia Parkin has nothing to disclose.
Melissa Armstrong, MD, MSc, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Divya M. Radhakrishnan, MD, DM (Neurology) The institution of Dr. Radhakrishnan has received research support from Indian Council of Medical Research, New Delhi, India. Dr. Radhakrishnan has received research support from International Parkinson's and Movement Disorders Society, Asian Oceanian Section . The institution of Dr. Radhakrishnan has received research support from All India Institute of Medical Sciences, New Delhi, India.
Arunmozhimaran Elavarasi, MD Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research.
Katherine Barnes, MD Mrs. Barnes has nothing to disclose.
Peter A. Silburn, MBBS, PhD, FRACP No disclosure on file
Carlos Henrique F. Camargo, MD, PhD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Camargo has nothing to disclose.
Melesilika Finau, MD Dr. Finau has nothing to disclose.
Shivika Chandra, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in Â鶹´«Ã½Ó³»­ Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Elisabeth Fine, PhD Elisabeth Fine, PhD has received personal compensation for serving as an employee of Voyager Therapeutics, Inc. Elisabeth Fine, PhD has received stock or an ownership interest from Voyager Therapeutics.
Robert Zivadinov, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Jacob Paulson Mr. Paulson has nothing to disclose.
Alexandra O. Duffy, MD, FÂ鶹´«Ã½Ó³»­ Dr. Duffy has nothing to disclose.
Julia M. Soto, MPH Julia Soto has nothing to disclose.
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Camille Michaud The institution of Camille Michaud has received research support from Canadian Institutes of Health Researsh (CIHR).
Ryan J. Case, PhD Dr. Case has received personal compensation for serving as an employee of NeuroDerm.
Caroline Johnson Caroline Johnson has nothing to disclose.
Fredy J. Revilla, MD, FÂ鶹´«Ã½Ó³»­ Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA .
Gabriel M. Napoli, MD Dr. Napoli has nothing to disclose.
Joshua Chodosh, MD The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NINR.
Remy Johnson Remy Johnson has nothing to disclose.
Rita Gandhy, MD Dr. Gandhy has received personal compensation for serving as an employee of Genentech.
Marie-Eve Gendron Marie-Eve Gendron has received personal compensation for serving as an employee of Merz Therapeutics.
Donald Gilbert, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Trevor Hawkins, MD Dr. Hawkins has nothing to disclose.
Zulema Salazar Salazar, MD Dr. Salazar Salazar has nothing to disclose.
Travis H. Turner, PhD Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for VeraSci. Dr. Turner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Saccadous. Dr. Turner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. The institution of Dr. Turner has received research support from NIH. The institution of Dr. Turner has received research support from Aker BioMarine.
Fariha Jamal No disclosure on file
Lauren Seeberger, MD, FÂ鶹´«Ã½Ó³»­ Dr. Seeberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocine Biosciences. Dr. Seeberger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Seeberger has received research support from Neurocrine. The institution of Dr. Seeberger has received research support from TEVA.
Steve Wu, MD The institution of Dr. Wu has received research support from Tourette Association of America.
Jeffrey D. Long Jeffrey Long has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Triplet. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vacinnex. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Jeffrey Long has received personal compensation in the range of $0-$499 for serving as a Consultant for PTC. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Jeffrey Long has received research support from NIH DSMB.
Samuel Hamner, PhD Dr. Hamner has received personal compensation for serving as an employee of Cala Health. Dr. Hamner has received stock or an ownership interest from Cala Health.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Federico Parisi, PhD Federico Parisi has nothing to disclose.
Richard Bertz Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Jeffrey Nie Jeffrey Nie has nothing to disclose.
Karin Wirdefeldt, MD The institution of Dr. Wirdefeldt has received research support from The Parkinson Foundation in Sweden. The institution of Dr. Wirdefeldt has received research support from Swedish Research Council.
Melanie Braun, MD Dr. Braun has nothing to disclose.
Xiaoying Kang Miss Kang has nothing to disclose.
Liat Adar Liat Adar has received personal compensation for serving as an employee of Neuroderm.
Alexander Ksendzovsky No disclosure on file
Victoria Wirtz Victoria Wirtz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Victoria Wirtz has stock in Biohaven.
James Rowe, BA BM BCh PhD James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SV Health. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astex. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Asceneuron. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of James Rowe, BA BM BCh PhD has received research support from Janssen. The institution of James Rowe, BA BM BCh PhD has received research support from Lilly. The institution of James Rowe, BA BM BCh PhD has received research support from AZ Medimmune. James Rowe, BA BM BCh PhD has received publishing royalties from a publication relating to health care.
Marta Allende Del Río No disclosure on file
Irena Pulte Irena Pulte has received personal compensation for serving as an employee of Merz Pharmaceuticals . Irena Pulte has received intellectual property interests from a discovery or technology relating to health care.
Christopher Domen Christopher Domen has nothing to disclose.
Anne Marie A. Wills, MD Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant, a CVS/Caremark company. Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi/Genzyme. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Wills has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Wills has received research support from Parkinson's Foundation. The institution of Dr. Wills has received research support from Biogen. The institution of Dr. Wills has received research support from Roche/Genentech. The institution of Dr. Wills has received research support from BioSensics.
Ramon L. Rodriguez Cruz, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Luciana V. Leon Cejas, MD Dr. Leon Cejas has nothing to disclose.
Rajesh Pahwa, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Johan W. Smit, PhD Joah Smit has received stock or an ownership interest from UCB Srl. Joah Smit has received personal compensation in the range of $100,000-$499,999 for serving as a director clinical pharmacology with UCB Srl.
Jonathan Jagid Jonathan Jagid has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miami Dade County State Attorneys office. The institution of Jonathan Jagid has received research support from Boston Scientific.
Eileen Sawyer, PhD Eileen Sawyer has received personal compensation for serving as an employee of uniQure Inc. Eileen Sawyer has received stock or an ownership interest from uniQure Inc.
Chong S. Lee, MD, FRCPC Dr. Lee has nothing to disclose.
Judy Lytle Judy Lytle has received personal compensation for serving as an employee of Adamas Pharmaceuticals, Inc. Judy Lytle has received stock or an ownership interest from Adamas Pharmaceuticals, Inc.
Achal K. Srivastava, MD, FÂ鶹´«Ã½Ó³»­ Dr. Srivastava has nothing to disclose.
Luigi Albano, MD Luigi Albano has nothing to disclose.
Todd Gross Todd Gross has received personal compensation for serving as an employee of Revance Therapeutics Inc. Todd Gross has stock in Revance Therapeutics Inc.
Vinay Goyal Goyal, MD, DM, FIAN Prof. Goyal has nothing to disclose.
Elizabeth Slow, MD, PhD Dr. Slow has nothing to disclose.
Lisa M. Deuel, MD Dr. Deuel has nothing to disclose.
Hubert H. Fernandez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Rose C. Healy, MD Miss Healy has nothing to disclose.
Amelia Carwin, MD Dr. Carwin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Carwin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin.
Sandeep Thakkar, DO Dr. Thakkar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for abbvie. Dr. Thakkar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Thakkar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine. Dr. Thakkar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Thakkar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for medtronic.
Nora Hernandez No disclosure on file
Todd Herrington, MD Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic, Inc. Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MarvelBiome. Dr. Herrington has received personal compensation in the range of $0-$499 for serving as an Expert Witness for CRICO. The institution of Dr. Herrington has received research support from NIH/NINDS (K23NS099380).
Yining Huang, PhD No disclosure on file
Derek Narendra, MD The institution of Dr. Narendra has received research support from National Institutes of Health.
Jorge Zamudio, MD, MBA Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received stock or an ownership interest from Abbvie .
Kenneth P. Martinez, MD The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. The institution of Dr. Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Martinez has received research support from Medtronic. The institution of Dr. Martinez has received research support from Abbvie/Allergan.
Anibal Chertcoff Anibal Chertcoff has nothing to disclose.
Varun P. Chaubal, MD Dr. Chaubal has nothing to disclose.
Sheila Oren, MD, MBA Sheila Oren, MD, MBA has received personal compensation for serving as an employee of Neuroderm. Sheila Oren, MD, MBA has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuroderm.
Yi Wang, PhD Prof. Wang has received intellectual property interests from a discovery or technology relating to health care.
Michele Tagliati, MD, FÂ鶹´«Ã½Ó³»­ Dr. Tagliati has received publishing royalties from a publication relating to health care.
Per Odin Per Odin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Britannia. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Convatec. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Akihisa Mori, PhD Mr. Mori has received personal compensation for serving as an employee of SNLD, Ltd., Japan.
Peter A. LeWitt, MD Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Norbert Kovacs Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie.
Ali Samii, MD, FRCP Dr. Samii has nothing to disclose.
Sohaila A. Alshimemeri, MD Dr. Alshimemeri has nothing to disclose.
Claudia Z. Chou, MD Dr. Chou has nothing to disclose.
Robert Gross No disclosure on file
Meghan C. Campbell, PhD The institution of Meghan C. Campbell has received research support from NIH. The institution of Meghan C. Campbell has received research support from NIH. The institution of Meghan C. Campbell has received research support from McDonnell Center for Systems Neuroscience. The institution of Meghan C. Campbell has received research support from WUSM Radiology Department. The institution of Meghan C. Campbell has received research support from NIH. Meghan C. Campbell has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson Foundation. Meghan C. Campbell has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense.
Danish Bhatti, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bhatti has nothing to disclose.
Julius B. Anang, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Anang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Anang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan.
Brian Kopell No disclosure on file
Aliya Sarwar, MD Dr. Sarwar has received personal compensation in the range of $500-$4,999 for serving as a Amneal Fellowship Director Advisory Board Member with Amneal -Rytary.
Jennifer Hislop, MD Dr. Hislop has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Veterans Affairs.
Ahmad El Kouzi, MD, FÂ鶹´«Ã½Ó³»­ Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Iresha Abeynayake Iresha Abeynayake has received personal compensation for serving as an employee of Axsome. Iresha Abeynayake has stock in Axsome.
Guenther Deuschl, MD, FÂ鶹´«Ã½Ó³»­ Dr. Deuschl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Cavion Functional Neuromodulation. The institution of Dr. Deuschl has received research support from Medtronic. Dr. Deuschl has received publishing royalties from a publication relating to health care.
Juebin Huang, MD, PhD Dr. Huang has nothing to disclose.
Thomas J. Guttuso, MD Dr. Guttuso has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Guttuso has received stock or an ownership interest from e3 Pharmaceuticals.
Steffen Paschen The institution of Steffen Paschen has received research support from Deutsche Forschungsgemeinschaft. The institution of Steffen Paschen has received research support from Parkinsonfonds. The institution of Steffen Paschen has received research support from UCB .
Virendra R. Mishra, PhD The institution of Prof. Mishra has received research support from Keep Memory Alive Young Scholar Award. The institution of Prof. Mishra has received research support from NINDS/NIA: R01NS117547-01. The institution of Prof. Mishra has received research support from NIGMS: P20GM109025.
Michelle Fullard, MD Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.
Sonya G. Wang, MD Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Tiffany Chen Tiffany Chen has nothing to disclose.
Rose Gelineau-Morel, MD Dr. Gelineau-Morel has nothing to disclose.
Christopher Goetz, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
S. Pablo Sardi, PhD Dr. Sardi has received personal compensation for serving as an employee of Sanofi. The institution of Dr. Sardi has received research support from MJFF.
Tuhin Virmani, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Virmani has received research support from Parkinson's Foundation.
Charbel E. Moussa, PhD, MB Dr. Moussa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for KeifeRX LLC. Dr. Moussa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharmaceuticals Research Industry. Dr. Moussa has received stock or an ownership interest from Orphan Therapeutics. The institution of Dr. Moussa has received research support from NIA. The institution of Dr. Moussa has received research support from Sun Pharmaceuticals Research Industry. The institution of Dr. Moussa has received research support from Alzheimer's Association . Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received publishing royalties from a publication relating to health care. Dr. Moussa has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with DG Information Technology. Dr. Moussa has received personal compensation in the range of $0-$499 for serving as a Peer Reviews with National Institutes of Health.
Anindita Deb, MD, FÂ鶹´«Ã½Ó³»­ Dr. Deb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec.
Meena Lanjiwar, DM Dr. Lanjiwar has nothing to disclose.
Junaid H. Siddiqui, MD Dr. Siddiqui has nothing to disclose.
Parunyou Julayanont, MD Dr. Julayanont has nothing to disclose.
Michela Leocadi, MSc Dr. Leocadi has nothing to disclose.
Petya Mihaylova Petya Mihaylova has nothing to disclose.
Lawrence Hewitt Lawrence Hewitt has received personal compensation for serving as an employee of Lundbeck.
Bichun Ouyang Bichum Ouyang has nothing to disclose.
Roopa Rajan Roopa Rajan has received research support from DBT. Roopa Rajan has received research support from DST-SERB. The institution of Roopa Rajan has received research support from Michael J Fox Foundaton.
Mohamed Elkasaby, MD Dr. Elkasaby has nothing to disclose.
Zain Guduru, MD, FÂ鶹´«Ã½Ó³»­ Dr. Guduru has nothing to disclose.
Paul Larson No disclosure on file
Jie Pan, MD Dr. Pan has nothing to disclose.
Mamta B. Singh, MD, MBBS, DM, FÂ鶹´«Ã½Ó³»­ Dr. Singh has nothing to disclose.
Ralf Reilmann, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for uniQure. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WAVE. Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WAVE. The institution of Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IOS-Press. The institution of Dr. Reilmann has received research support from European Union. Dr. Reilmann has a non-compensated relationship as a Executive Committee Member with Huntington Study Group that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reilmann has a non-compensated relationship as a Member of Executive Committee with European Huntington Disease Network that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reilmann has a non-compensated relationship as a Co-Chair Task Force on Huntington Disease with Movement Disorders Socitey that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Alonso Zea Vera, MD The institution of Dr. Zea Vera has received research support from American Brain Foundation, Tourette Association of America, Â鶹´«Ã½Ó³»­.
Danielle N. Thordarson, MD Dr. Thordarson has nothing to disclose.
Vladana Markovic No disclosure on file
Eunice Chang No disclosure on file
Gabriela Raina No disclosure on file
Francisco Rocha Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Riadh Gouider, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Wayne W. Feng, MD, FÂ鶹´«Ã½Ó³»­ Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Lisa L. Barnes, PhD Lisa L. Barnes has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. The institution of Lisa L. Barnes has received research support from NIH. Lisa L. Barnes has received personal compensation in the range of $500-$4,999 for serving as a Council member with NACMHD.
Michael Soileau, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Soileau has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Soileau has received research support from Abbvie. The institution of Dr. Soileau has received research support from Cerevel. The institution of Dr. Soileau has received research support from Praxis. The institution of Dr. Soileau has received research support from CND Life Sciences. The institution of Dr. Soileau has received research support from Teva. The institution of Dr. Soileau has received research support from Abbott. The institution of Dr. Soileau has received research support from Jazz Pharmaceuticals. The institution of Dr. Soileau has received research support from Scion. Dr. Soileau has received publishing royalties from a publication relating to health care. Dr. Soileau has a non-compensated relationship as a Past President with Texas Neurological Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Aliyah J. Glover Miss Glover has nothing to disclose.
Lahoud Touma, MD Dr. Touma has nothing to disclose.
Ethan G. Brown, MD Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Julia Shirvan, MD No disclosure on file
John R. Absher, MD, FÂ鶹´«Ã½Ó³»­ Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehabilitation Alternative Services, Inc.. Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Butler, Means, Evins and Browne, P.A..
Alina Shub, PA The institution of Ms. Shub has received research support from Abbott and Boston Scientific .
Grace Yoon, MD Dr. Yoon has nothing to disclose.
Mitra Afshari, MD Dr. Afshari has received research support from Consolidated Anti-Aging Foundation . Dr. Afshari has received research support from Parkinson Study Group.
Kara M. Smith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Consultant for PureTech. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec Inc. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Massachusetts Board of Medicine. The institution of Dr. Smith has received research support from NIH. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a single time expert panel discussion contributor with Acadia.
Marisa McGhee, MD Dr. McGhee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. McGhee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Shannon O'Neill, PhD Shannon O'Neill has nothing to disclose.
Mustafa S. Siddiqui, MD, FÂ鶹´«Ã½Ó³»­ Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Masharip Atadzhanov, MD, PhD, DSc, FRCP, FÂ鶹´«Ã½Ó³»­ Dr. Atadzhanov has nothing to disclose.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
José Miguel Ramírez Sanz No disclosure on file
Saloni Sharma, MBBS Dr. Sharma has nothing to disclose.
Pascal Maisonobe Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Lorraine Chishimba, MBChB, MMED Dr. Chishimba has nothing to disclose.
Mihaela A. Simu, MD, PhD Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis PHarma . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Romania. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson &Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofy Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson&Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ewopharma A G. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen.
Meghan E. Pawlik, MS Miss Pawlik has nothing to disclose.
Butchi Raju Garuda, MD, FÂ鶹´«Ã½Ó³»­ Dr. Garuda has nothing to disclose.
Carolina Gorodetsky, MD Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic Inc .
Daniel Weintraub Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Sharan Paul, PhD Dr. Paul has nothing to disclose.
Deepmala Nandanwar, MD Dr. Nandanwar has nothing to disclose.
Prasanna L. Kandukuri Mrs. Kandukuri has nothing to disclose.
Luhua Wei Luhua Wei has nothing to disclose.
Jori Fleisher, MD, MSCE, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with Â鶹´«Ã½Ó³»­ Brain & Life Magazine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Jill M. Farmer, DO, MPH Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Farmer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Live. The institution of Dr. Farmer has received research support from Parkinson's Foundation.
Chandler Gill, MD Dr. Gill has nothing to disclose.
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Andrew S. Feigin, MD Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
James F. Morley, MD, PhD Dr. Morley has nothing to disclose.
Christina Kallik, MD Dr. Kallik has nothing to disclose.
Elana Farace, PhD Dr. Farace has nothing to disclose.
Saad I. Yazdani, MD Dr. Yazdani has nothing to disclose.
Christopher Ross, MD, PhD Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniqure. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitoconix. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuBase. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Huntington Study Group. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitoconix. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuBase. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mintz. Christopher Ross, MD, PhD has received intellectual property interests from a discovery or technology relating to health care. Christopher Ross, MD, PhD has a non-compensated relationship as a consultant with Huntington Study Group that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Caroline Olvera, MD Dr. Olvera has nothing to disclose.
Patricio Soares-da-Silva Patricio Soares-da-Silva has received personal compensation for serving as an employee of Bial - Portela & Cª S.A.. Patricio Soares-da-Silva has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Bial - Portela & Cª S.A..
Robert A. Hauser, MD, MBA, FÂ鶹´«Ã½Ó³»­ Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Sinead Murphy Sinead Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Sinead Murphy has received research support from Novartis.
Daniel O. Claassen, MD, FÂ鶹´«Ã½Ó³»­ Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Pierpaolo Turcano, MD Dr. Turcano has nothing to disclose.
Kanchana S. Pillai, MD Dr. Pillai has nothing to disclose.
Duncan Street, MBBS, MRCP Dr. Street has nothing to disclose.
Ana Jimena Hernandez Medrano Miss Hernandez Medrano has nothing to disclose.
Fahd Amjad, MD Dr. Amjad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TEVA. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Amjad has received personal compensation in the range of $0-$499 for serving as a Consultant for abbvie. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyowna Kirin. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for This information is included in the consultant disclosure. The institution of Dr. Amjad has received research support from Roche.
Smathorn Thakolwiboon, MD Dr. Thakolwiboon has nothing to disclose.
Marieta Anca-Herschkovitsch, MD Marieta Anca-Herschkovitsch, MD has nothing to disclose.
Feiby L. Nassan No disclosure on file